CollectivIQ, the world's first AI consensus platform for business intelligence, today announced a major expansion of its platform to help companies drive meaningful AI value. The platform ...
Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results